Precision Oncology company 4baseCare has signed a Memorandum of Understanding (MoU) with the Government of Maharashtra to establish a Centre of Excellence for Precision Oncology, marking a significant step toward advancing cancer care in the state. The collaboration aims to integrate genomic-based cancer care into Maharashtra’s public healthcare system. The initiative is designed to enable more personalized and data-driven treatment approaches, allowing oncologists to make informed decisions based on each patient’s genetic profile.
What is Precision oncology?
Precision oncology is a modern approach to cancer treatment where therapy is tailored to an individual patient’s genetic makeup and the specific characteristics of their tumor rather than using a one-size-fits-all treatment. It is a part of Oncology that focuses on delivering personalized care using scientific and molecular insights.
How It Works
In precision oncology, advanced technologies such as genomic sequencing and biomarker analysis are used to study the tumor at a molecular level. These tests help identify specific mutations or abnormalities in cancer cells. Based on this information, doctors can select targeted therapies, immunotherapy, or other personalized treatment options that are most effective for the patient.
As part of the agreement, 4baseCare will deploy its AI-powered OncoTwin platform, which maps patients’ genomic and clinical data against real-world outcomes to generate treatment insights. The platform is expected to support oncologists in delivering evidence-based and tailored cancer therapies. The proposed Centre of Excellence will be equipped with advanced technologies such as Next Generation Sequencing (NGS) to facilitate genomic profiling of cancer patients. This will help in identifying precise treatment pathways and improving clinical outcomes through targeted therapies.
The MoU was signed during the PULSE 2026 summit in Mumbai where the Maharashtra government entered into multiple partnerships to strengthen healthcare infrastructure and innovation. The initiative aligns with the state’s broader vision to build a future-ready and inclusive healthcare ecosystem under long-term development plans. Company officials stated that the collaboration will help expand access to advanced cancer diagnostics and treatment across government healthcare institutions. The centre will also contribute to building clinico-genomic datasets, supporting research and improving cancer care delivery across the state.
The partnership between 4baseCare and the Maharashtra government represents a major advancement in integrating artificial intelligence and genomics into public healthcare. By establishing a precision oncology centre, the initiative is expected to enhance cancer care accessibility, promote personalized treatment, and strengthen the state’s healthcare capabilities.